Luo, T.; Peng, J.; Li, Q.; Zhang, Y.; Huang, Y.; Xu, L.; Yang, G.; Tan, D.; Zhang, Q.; Tan, Y.
GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma. Int. J. Mol. Sci. 2022, 23, 13740.
https://doi.org/10.3390/ijms232213740
AMA Style
Luo T, Peng J, Li Q, Zhang Y, Huang Y, Xu L, Yang G, Tan D, Zhang Q, Tan Y.
GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma. International Journal of Molecular Sciences. 2022; 23(22):13740.
https://doi.org/10.3390/ijms232213740
Chicago/Turabian Style
Luo, Tengling, Junwei Peng, Qijun Li, Yao Zhang, Yun Huang, Lei Xu, Genling Yang, Dongmei Tan, Qian Zhang, and Yi Tan.
2022. "GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma" International Journal of Molecular Sciences 23, no. 22: 13740.
https://doi.org/10.3390/ijms232213740
APA Style
Luo, T., Peng, J., Li, Q., Zhang, Y., Huang, Y., Xu, L., Yang, G., Tan, D., Zhang, Q., & Tan, Y.
(2022). GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma. International Journal of Molecular Sciences, 23(22), 13740.
https://doi.org/10.3390/ijms232213740